Wells Fargo analyst Christopher Carey maintained a Buy rating on Molson Coors (TAP – Research Report) yesterday and set a price target of ...
Molson Coors Beverage Company has announced a strategic partnership with Fever-Tree in the US, aiming to fuel its ...
The deal gives Molson Coors exclusive commercialization rights to Fever-Tree’s U.S. portfolio, alongside an equity investment by Molson Coors into Fevertree Drinks plc Partnership designed to fuel ...
As part of the agreement, the beer giant will manage the sales, distribution and production of Fevertree’s products in the US ...
The Coors Light brewer will pay £71 million ($88 million) for 8.5% of Fevertree, a move that will help the Chicago-based company expand its non-alcoholic range.